EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The impact of hypoglycaemia on quality of life among adults with type 1 diabetes: Results from “YourSAY: Hypoglycaemia”

Hannah Chatwin, Melanie Broadley, Christel Hendrieckx, Jill Carlton, Simon Heller, Stephanie A Amiel, Bastiaan de Galan, Rory J McCrimmon, Ulrik Pedersen-Bjergaard, Frans Pouwer, Jane Speight, Hypo-RESOLVE Consortium

Journal of Diabetes and its Complications · 2023-11 · 37 (11) · 108232

DOI: 10.1016/j.jdiacomp.2022.108232 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Diabetes and its Complications, 2023-11. Verfasst von Hannah Chatwin und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychology, University of Southern Denmark, Odense, Denmark; National Centre for Register-based Research, Aarhus BSS, Aarhus University…. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 1, Hypoglycemia. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Juvenile Diabetes Research Foundation United States of America, Deakin University, International Dragonfly Fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

AIMS: Research on hypoglycaemia and quality of life (QoL) has focused mostly on severe hypoglycaemia and psychological outcomes, with less known about other aspects of hypoglycaemia (e.g., self-treated episodes) and impacts on other QoL domains (e.g., relationships). Therefore, we examined the impact of all aspects of hypoglycaemia on QoL in adults with type 1 diabetes (T1DM). METHODS: Participants completed an online survey, including assessment of hypoglycaemia-specific QoL (using the 12-item Hypoglycaemia Impact Profile). Mann-Whitney U tests examined differences in hypoglycaemia-specific QoL by hypoglycaemia frequency, severity, and awareness. Hierarchical linear regression examined associations with QoL. RESULTS: Participants were 1028 adults with T1DM (M ± SD age: 47 ± 15 years; diabetes duration: 27 ± 16 years). Severe and self-treated hypoglycaemia and impaired awareness negatively impacted on overall QoL and several QoL domains, including leisure activities, physical health, ability to keep fit/be active, sleep, emotional well-being, spontaneity, independence, work/studies, and dietary freedom. Diabetes distress was most strongly associated with hypoglycaemia-specific QoL, followed by generic emotional well-being, fear of hypoglycaemia, and confidence in managing hypoglycaemia. Hypoglycaemia frequency and awareness were no longer significantly associated with QoL once psychological factors were considered. CONCLUSIONS: Hypoglycaemia negatively impacts on several QoL domains. Psychological factors supersede the effect of hypoglycaemia frequency and awareness in accounting for this negative impact.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 1HypoglycemiaAdultHumansMiddle AgedHypoglycemic AgentsQuality of LifeFear

Stichwörter der Autor:innen

Fear of hypoglycaemiaHypoglycaemiaPsychological functioningQuality of lifeT1DMWell-being

Substanzen

Hypoglycemic Agents

Autor:innen und Institutionen

  • Department of Psychology, University of Southern Denmark, Odense, Denmark; National Centre for Register-based Research, Aarhus BSS, Aarhus University, Denmark. Electronic address: hchatwin@econ.au.dk.
  • Department of Psychology, University of Southern Denmark, Odense, Denmark.
  • School of Psychology, Deakin University, Geelong, Australia; The Australian Centre for Behavioural Research in Diabetes, Diabetes Victoria, Melbourne, Australia.
  • School of Health Related Research, University of Sheffield, Sheffield, United Kingdom.
  • Department of Oncology and Metabolism, University of Sheffield, Sheffield, United Kingdom.
  • Department of Diabetes, King's College London, London, United Kingdom.

Förderung

  • Juvenile Diabetes Research Foundation United States of America
  • Deakin University
  • International Dragonfly Fund
  • Novo Nordisk
  • Abbott Diabetes Care
  • Innovative Medicines Initiative
  • European Federation of Pharmaceutical Industries and Associations
  • Diabetes Victoria

Zitieren

APA

Chatwin, H., Broadley, M., Hendrieckx, C., Carlton, J., Heller, S., Amiel, S. A., de Galan, B., McCrimmon, R. J., Pedersen-Bjergaard, U., Pouwer, F., Speight, J., & Hypo-RESOLVE Consortium (2023). The impact of hypoglycaemia on quality of life among adults with type 1 diabetes: Results from “YourSAY: Hypoglycaemia”. Journal of Diabetes and its Complications, 37(11), 108232. https://doi.org/10.1016/j.jdiacomp.2022.108232

Vancouver

Chatwin H, Broadley M, Hendrieckx C, Carlton J, Heller S, Amiel SA, et al. The impact of hypoglycaemia on quality of life among adults with type 1 diabetes: Results from “YourSAY: Hypoglycaemia”. Journal of Diabetes and its Complications. 2023;37(11):108232. doi:10.1016/j.jdiacomp.2022.108232

BibTeX
@article{Chatwin2023,
  author = {Chatwin, Hannah and Broadley, Melanie and Hendrieckx, Christel and Carlton, Jill and Heller, Simon and Amiel, Stephanie A and de Galan, Bastiaan and McCrimmon, Rory J and Pedersen-Bjergaard, Ulrik and Pouwer, Frans and Speight, Jane and Hypo-RESOLVE Consortium, Hypo-RESOLVE Consortium},
  title = {The impact of hypoglycaemia on quality of life among adults with type 1 diabetes: Results from “YourSAY: Hypoglycaemia”},
  journal = {Journal of Diabetes and its Complications},
  year = {2023},
  volume = {37},
  number = {11},
  pages = {108232},
  doi = {10.1016/j.jdiacomp.2022.108232}
}
Kostenlos starten →